Evotec SE EVO
NASDAQ EVO
$1.95 -0.01 (-0.51%)
As of: Aug 21, 2026 · 12:19 PM EDT

Evotec SE (EVO) Operating Margin Growth (5y) (2024 - 2025)

Evotec SE (EVO) Operating Margin Growth (5y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.36 Bn 43.40 Bn -
2 Teva Pharmaceutical Industries 43.73 Bn 40.08 Bn 2.15 Bn
3 Zoetis 32.52 Bn 30.84 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 22.14 Bn 19.48 Bn 683.80 Mn
6 Viatris 18.93 Bn 18.04 Bn 1.46 Bn
7 Neurocrine Biosciences 15.49 Bn 15.10 Bn 935.80 Mn
8 Elanco Animal Health 12.00 Bn 11.47 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.15 Bn 9.98 Bn -
10 Evotec SE 692.56 Mn 692.08 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,125.00
Dec 31, 2024 -1,152.00